Stroke/Cerebrovascular Disease Perspective

  • COMMANDER HF: What Now for Anticoagulation in Heart Failure?   Drs Ileana Piña and Mandeep Mehra discuss the neutral results of the COMMANDER HF trial on rivaroxaban in patients with heart failure in sinus rhythm.
  • The Latest Attack on Low-Carb Diets: Science or Politics? A recent paper in Lancet Public Health announced that low-carb diets are associated with increased mortality. But are the study's conclusions based on sound scientific evidence?
  • Beta-Blockade After MI: No Practice Should Be Set in Stone Meta-analyses suggest little benefit for beta-blockers in contemporary patients with normal ejection fraction after MI. What other dogma should be revisited in light of an evolving evidence base?
  • Who Is the 'Cardiometabolic Specialist'?   With new diabetes drugs available that lower cardiovascular risk, the question arises over which specialty will manage this area of medicine. Or will a new specialty emerge?
  • ESC 2018Aspirin in Primary Prevention: Lessons From ASCEND   The ESC hotline ASCEND trial on low-dose aspirin for primary CV prevention in people with diabetes is reviewed with presenter Prof Armitage.
  • ESC 2018Don't Ignore the Many Lessons of the MitraClip Failure Reflecting on the MITRA-FR trial, Dr John Mandrola says it can help us learn both specific lessons about the treatment of people with heart failure and more general lessons on the acceptance of untested therapeutics.
  • ESC 2018Do Cardiologists Care About CV Prevention? Everyone agrees that prevention is better than cure. However, few ESC attendees joined Melissa Walton-Shirley for the session on CVD prevention, preferring to stand in line to hear the latest hotlines.
  • ESC 2018Aspirin in Primary Prevention: Lessons From ARRIVE   The ARRIVE trial compared low-dose aspirin with placebo in middle-aged men and women at moderate CV risk. Investigator J. Michael Gaziano gives John Mandrola the details.
  • Stroke Trials at ESOC 2018: 'Lots of Excitement'   Neurologist Dr Christoph Diener reviews four pivotal stroke trials presented at ESOC 2018.
  • LDL: When Is It Low Enough?   When we aim for ever-lower LDL levels, do we see more benefit or diminishing returns?
  • Mandrola's ESC 2018 Preview From aspirin to VTE, John Mandrola reflects on the potpourri of relevant data for the practicing clinician at this year's European Society of Cardiology Congress.
  • Be Aware of These Nine Questionable Clinics Integrative medicine, bogus cancer treatment, antiaging, low T, and more -- what do you need to know about the proliferation of these clinics in medicine?
  • 5 Dietary Tips to Share With Your Patients With the constant barrage of nutrition and diet advice, it's difficult to know what 'healthy eating' really means. Here are five simple evidence-based tips to share when counseling your patients.
  • Atrial Fibrillation: What's New? Not Much An investigation of AF trials on found few studies of high scientific rigor. John Mandrola, MD, ponders the implications for patient management.
  • Four New Studies in Neurology   Dr Diener reviews four studies likely to change the practice of neurology that encompass PFO closure in cryptogenic stroke, new treatments for migraine and glioblastoma, and tried-and-true treatments for MS.
  • The Most Perfect Medical Device of 2018   The best medical device of the year may already be in most of our homes.
  • AAN 2018A Computer Algorithm That Guides Stroke Care   Dr Mark Alberts discusses the benefits of using a CT profusion computer algorithm to identify patients with ischemic stroke who are candidates for thrombectomy.
  • Guideline vs Physician: Which Do You Trust?   Guidelines were meant to make treatment decisions easier and more evidence-based, but it hasn't quite worked out that way, says Dr Lundberg.
  • Ready Patient One: Video Games as Therapy Digital medicine seems poised to enter the mainstream. Medscape speaks with three researchers in this burgeoning field.
  • 'Time Is Brain': How Mobile Stroke Units Are Saving Lives Medscape spoke with Dr Andrei V. Alexandrov about mobile stroke units with state-of-the-art CT scanners capable of full CT angiography in the field, and how they are changing stroke care.
look on

our company